Sg3 Management, LLC Sio Gene Therapies Inc. Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.25 - $0.73 $25 - $73	-100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $220 - $588	-400 Reduced 80.0%	100 $0
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $905 - $1,350	500 New	500 $1,000
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $46,575 - $65,025	-22,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $79,560 - $116,960	-34,000 Reduced 60.18%	22,500 $59,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $107,915 - $318,095	56,500 New	56,500 $157,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.